You are here : Home / All Sectors / Healthcare / Pharmaceuticals & Drugs / SUN PHARMACEUTICAL INDUSTRIES

SUN PHARMACEUTICAL INDUSTRIES
Intrinsic Value | Fundamental Analysis

Returns | 1W : 0.3% , 1M : 7%,1Y : 67.1%
www.sunpharma.com
BOM : 524715     NSE : SUNPHARMA    
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Good [Stock is Cheap]
Debt : Low
Updated:
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Upward
Pledged Shares : None or < 25%
Oct 18,2021
Price(EOD): Rs. 835.20
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
Affiliate Link.
Stock Market Investing Simplified- The best Video Course by Smart-Investing.in

Check out Industry Peers

Peers & Returns1W1M1Y
SUN PHARMACEUTICAL INDUSTRIES 0.3% 7% 67.1%
DIVIS LABORATORIES 3.8% 3.4% 70.9%
DR REDDYS LABORATORIES -0.4% -1.2% -4%
CIPLA -1.1% -5.3% 15.6%
GLAND PHARMA -1.6% -7.1% NA
PIRAMAL ENTERPRISES 2.3% 6.4% 121.8%
CADILA HEALTHCARE -2.5% -5.3% 26.5%
TORRENT PHARMACEUTICALS -1.8% -0% 11.4%
ALKEM LABORATORIES -1.6% -0.2% 44.9%


FUNDAMENTAL ANALYSIS OF SUN PHARMACEUTICAL INDUSTRIES

 
Fundamentals Score
[ Q(TTM): Jun2021, Y: Mar2021
Q : Last Qtr data
Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
]
Show Me the Stocks with Fundamentals better than SUN PHARMACEUTICAL INDUSTRIES Plus/Pro


VALUATION OF SUN PHARMACEUTICAL INDUSTRIES

 
Valuation Score
[As on : Oct 18,2021 ]

Ratio Consolidated
P/E
P/B
P/S
69.02
P/E Calculated based on EPS of 12.1
[ Mar2021 - Consolidated Results ]

4.31
P/B Calculated based on Book Value of 193.65
[ Mar2021 - Consolidated Results ]

5.62
P/S Calculated based on Revenues of 35631.6 Cr
[ TTM - Consolidated Results ]

Show Me the Stocks with Valuation better than SUN PHARMACEUTICAL INDUSTRIES Plus/Pro


FAIR VALUE OF SUN PHARMACEUTICAL INDUSTRIES

 
Model Discount(-)/
Premium(+)
EV/EBIDTA
EV/Sales
Price/Sales
18%
-23%
-26%

SHARE PRICE MOMENTUM OF SUN PHARMACEUTICAL INDUSTRIES

DEBT

Year Debt/Equity ratio
Standalone Consolidated
2021
2020
2019
Avg_3yrs
0.27
0.26
0.28
0.27
0.08
0.18
0.25
0.17
[Last Annual Data : Mar2021]

PLEDGED SHARES

Pledged Shares
6.36 %
As on : Jun2021

If less than 25%

Good
If between 25% and 50% Neutral
If greater than 50% Bad

QTRLY RESULTS

Consolidated Q-o-Q Y-o-Y
Revenue
Op Profit
Profit Before Tax
Profit After Tax
14.03%
33.82%
99.79%
66.11%
28.13%
55.37%
182.62%
157.97%
QtrlyTrend
8
Latest Qtr: Jun2021

SUN PHARMACEUTICAL INDUSTRIES related INDICES

BSE Indices1W1M1Y
S&P BSE GREENEX 3.8% 6.5% 64.1%
MFG 3.8% 5.8% 53.2%
S&P BSE 100 ESG INDEX 3.4% 5.1% 55.2%
S&P BSE CARBONEX 3.3% 5.3% 55.6%
S&P BSE LARGE MIDCAP 3.1% 5.1% 58.2%
S&P BSE 200 3.1% 5% 59.2%
S&P BSE 100 3.1% 4.9% 55.9%
S&P BSE 250 LARGEMIDCAP 3% 5% 59.9%
S&P BSE LARGECAP 3% 4.8% 54.6%
S&P BSE 500 3% 5.2% 62%
S&P BSE 100 LARGECAP TMC 3% 4.6% 55.4%
S&P BSE ALLCAP 3% 5.3% 63.3%
S&P BSE SENSEX50 2.9% 4.7% 53.6%
S&P BSE SENSEX 2.7% 4.4% 51%
S&P BSE 500 SHARIAH 1.8% 3% 57%
S&P BSE DIVIDEND STABILITY 1.2% 9.1% 67.7%
S&P BSE HEALTHCARE -0.3% -2.3% 29.7%
NSE Indices1W1M1Y
NIFTY 200 3.1% 5.1% 59.1%
NIFTY50 EQUAL WEIGHT 3.1% 5.6% 72.8%
NIFTY 500 3% 5.2% 61.8%
NIFTY 50 3% 4.8% 53.7%
NIFTY 100 3% 4.5% 55.1%
NIFTY 100 EQUAL WEIGHT 2.9% 4.3% 69.5%
NIFTY LARGE MIDCAP 250 2.7% 5.6% 68.8%
NIFTY500 MULTICAP 50:25:25 2.6% 5.5% NA
NIFTY100 LIQ 15 1.8% 4.8% 73.6%
NIFTY HEALTHCARE 1.3% -1.3% NA
NIFTY PHARMA -0.1% 0.7% 21.2%

You may also like the below Video Courses


FAQ [Frequently Asked Questions]


Is SUN PHARMACEUTICAL INDUSTRIES good for long term investment?

As on 18-Oct-2021, the Fundamentals of SUN PHARMACEUTICAL INDUSTRIES look Strong and hence it may be good for long term investment! See Financial Performance of SUN PHARMACEUTICAL INDUSTRIES . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!

Is SUN PHARMACEUTICAL INDUSTRIES UnderValued or OverValued?

As on 18-Oct-2021, SUN PHARMACEUTICAL INDUSTRIES is Under Valued based on the estimates of intrinsic value and hence may be a good buying opportunity according to Share Valuation at this time!

What is the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES ?

As on 18-Oct-2021, the Intrinsic Value of SUN PHARMACEUTICAL INDUSTRIES is Rs. 1,086.20 determined based on Median of the 3 historical models.
Fair Value [Median EV / EBIDTA Model] : Rs. 709.99
Fair Value [Median EV / Sales Model] : Rs. 1,086.20
Fair Value [Median Price / Sales Model] : Rs. 1,123.57
Median Fair Value of SUN PHARMACEUTICAL INDUSTRIES : Rs. 1,086.20

Is SUN PHARMACEUTICAL INDUSTRIES trading at a Premium or Discount?

As on 18-Oct-2021, SUN PHARMACEUTICAL INDUSTRIES is trading at a Discount of -23% based on the estimates of Median Intrinsic Value!

What is the Financial Performance of Industry Peers of SUN PHARMACEUTICAL INDUSTRIES ?

Check out Annual Financials of Industry Peers
Share Price & Financials of DIVIS LABORATORIES LTD | BOM: 532488 | NSE: DIVISLAB
Share Price & Financials of DR REDDYS LABORATORIES LTD | BOM: 500124 | NSE: DRREDDY
Share Price & Financials of CIPLA LTD | BOM: 500087 | NSE: CIPLA
Share Price & Financials of GLAND PHARMA LTD | BOM: 543245 | NSE: GLAND
Check out Quarterly Results of Industry Peers
Quarterly Results of DIVIS LABORATORIES LTD
Quarterly Results of DR REDDYS LABORATORIES LTD
Quarterly Results of CIPLA LTD
Quarterly Results of GLAND PHARMA LTD

What are the Frequent Comparisons in this Industry?

Compare Analytics
SUN PHARMACEUTICAL INDUSTRIES LTD vs DIVIS LABORATORIES LTD vs DR REDDYS LABORATORIES LTD
CIPLA LTD vs GLAND PHARMA LTD vs PIRAMAL ENTERPRISES LTD
CADILA HEALTHCARE LTD vs TORRENT PHARMACEUTICALS LTD vs ALKEM LABORATORIES LTD
LUPIN LTD vs AUROBINDO PHARMA LTD vs BIOCON LTD
ABBOTT INDIA LTD vs LAURUS LABS LTD vs IPCA LABORATORIES LTD
Browse Market Cap of Industry Peers
Market Cap of DIVIS LABORATORIES LTD
Market Cap of DR REDDYS LABORATORIES LTD
Market Cap of CIPLA LTD
Market Cap of GLAND PHARMA LTD

Disclosure

SEBI Research Analyst
The Founder of this website, Mr. Rohit Katiyar is registered with SEBI as a Research Analyst [INH000007377].


All Stocks : A - Z

ALL   A  B  C  D  E  F  G  H  I  J  K  L  M  N  O  P  Q  R  S  T  U  V  W  X  Y  Z